The market implication is not just a better growth path for NOW; it is a proof point that enterprise software can shift pricing power from seats to outcomes without destroying retention. That matters because the valuation debate has been anchored on the assumption that AI monetization would be additive but marginal; if usage becomes the billing unit, the company can expand wallet share inside the same account base while defending margins through higher gross profit per workflow. The cleaner takeaway is that NOW may deserve a premium to both legacy SaaS and many AI-enabler names because it sits closer to measurable business processes, where customers can justify variable spend more easily.

Second-order winners are the software names that can credibly sell ROI-linked consumption, while the clearest losers are the low-differentiation seat-based vendors that still rely on headcount growth. If this model proves durable, it raises the bar for the entire sector: investors will start asking which names have usage-based attach, which have AI features that actually expand ACV, and which are simply bundling copilots into flat renewals. That dynamic could pressure higher-multiple peers in WCLD/IGV and force a relative rotation toward platform software with deeper workflow control.

The near-term catalyst is not the long-dated AI revenue number; it is the next two earnings prints, where investors should watch for billings mix, consumption acceleration, and whether gross margin holds as AI usage scales. The main risk is that consumption revenue creates more volatility than the market wants, causing visibility multiple compression if macro softens or usage ramps slower than expected. A clean falsifier would be any sign that AI-related demand is cannibalizing seat expansion, weakening cRPO growth, or failing to translate into operating leverage over the next 1-3 quarters.